サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1487617

mRNAワクチン市場：世界の産業分析、規模、シェア、成長、動向、2024年～2034年予測

mRNA Vaccine Market (Application: Covid-19, and Others; and End-user: Government Entities, Private Hospitals & Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 146 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
mRNAワクチン市場：世界の産業分析、規模、シェア、成長、動向、2024年～2034年予測
出版日: 2024年04月12日
発行: Transparency Market Research
ページ情報: 英文 146 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

mRNAワクチン市場- 調査範囲

TMRの世界mRNAワクチン市場に関する調査レポートは、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2024年を基準年、2034年を予測年として、2018年から2034年までの世界のmRNAワクチン市場の収益と予測を提供します。また、2024年から2034年までの世界のmRNAワクチン市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、mRNAワクチン市場を理解しました。

市場スナップショット
2023年の市場規模 217億米ドル
2034年の市場価値 96億米ドル
CAGR -4.3%

本レポートでは、世界のmRNAワクチン市場の競合情勢について掘り下げています。世界のmRNAワクチン市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のmRNAワクチン市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 調査前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場の分析と予測、2020年～2034年
  • ポーターのファイブフォース分析

第5章 主要な洞察

  • 技術の進歩
  • パイプライン
  • 地域/世界別の規制シナリオ
  • COVID-19パンデミックの産業への影響分析

第6章 世界市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 用途別市場金額予測、2020年～2034年
    • COVID-19
    • その他
  • 用途別市場魅力度

第7章 世界市場分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • エンドユーザー別市場金額予測、2020年～2034年
    • 政府機関
    • 民間病院・クリニック
    • その他
  • エンドユーザー別市場魅力度

第8章 世界市場分析・予測：地域別

  • 主な調査結果
  • 地域別市場金額予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別市場魅力度

第9章 北米市場の分析と予測

  • 米国
  • カナダ

第10章 欧州市場の分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州

第11章 アジア太平洋市場の分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリア・ニュージーランド
  • その他アジア太平洋

第12章 ラテンアメリカ市場の分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ

第13章 中東・アフリカ市場の分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第14章 競合情勢

  • 市場競合マトリックス（ティア別、企業規模別）
  • 企業シェア分析（2022年）
  • 企業プロファイル
    • Pfizer, Inc.
    • Moderna Inc.
    • Novartis AG
    • Sanofi
    • Arcturus Therapeutics
    • Gennova Biopharmaceuticals Ltd
    • Aimei Vaccine Co., Ltd
図表

List of Tables

  • Table 01: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 02: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 03: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 04: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 05: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 06: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 07: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 08: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 09: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 10: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 11: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 12: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 13: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 15: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 16: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 18: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

List of Figures

  • Figure 01: Global mRNA Vaccine Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global mRNA Vaccine Market Value Share, By Application, 2023
  • Figure 03: Global mRNA Vaccine Market Value Share, by End-User, 2023
  • Figure 04: Global mRNA Vaccine Market Value Share, by Region, 2023
  • Figure 05: Global mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 06: Global mRNA Vaccine Market Share Analysis, by Application, 2023
  • Figure 07: Global mRNA Vaccine Market Share Analysis, by Application, 2034
  • Figure 08: Global mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 09: Global mRNA Vaccine Market Value (US$ Mn), by COVID-19, 2020-2034
  • Figure 10: Global mRNA Vaccine Market Value Share Analysis, by COVID-19, 2023 and 2034
  • Figure 11: Global mRNA Vaccine Market Value (US$ Mn), by Others, 2020-2034
  • Figure 12: Global mRNA Vaccine Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 13: Global mRNA Vaccine Market Value (US$ Mn) Share Analysis, by End-User, 2023 and 2034
  • Figure 14: Global mRNA Vaccine Market Share Analysis, by End-User, 2023
  • Figure 15: Global mRNA Vaccine Market Share Analysis, by End-User, 2034
  • Figure 16: Global mRNA Vaccine Market Attractiveness Analysis, by End-User, 2024-2034
  • Figure 17: Global mRNA Vaccine Market Value (US$ Mn), by Government Entities, 2020-2034
  • Figure 18: Global mRNA Vaccine Market Value Share Analysis, by Government Entities, 2023 and 2034
  • Figure 19: Global mRNA Vaccine Market Value (US$ Mn), by Private Hospitals & Clinics, 2020-2034
  • Figure 20: Global mRNA Vaccine Market Value Share Analysis, by Private Hospitals & Clinics, 2023 and 2034
  • Figure 21: Global mRNA Vaccine Market Value (US$ Mn), by Others, 2020-2034
  • Figure 22: Global mRNA Vaccine Market Value Share Analysis, by Other, 2023 and 2034
  • Figure 23: Global mRNA Vaccine Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 24: Global mRNA Vaccine Market Share Analysis, by Region, 2023
  • Figure 25: Global mRNA Vaccine Market Share Analysis, by Region, 2034
  • Figure 26: Global mRNA Vaccine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 27: North America mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 28: North America mRNA Vaccine Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 29: North America mRNA Vaccine Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 30: North America mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 31: North America mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 32: North America mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 33: North America mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 34: Europe mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 35: Europe mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 37: Europe mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 38: Europe mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 39: Europe mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 40: Europe mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 41: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 42: Asia Pacific mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 43: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 44: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 45: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 46: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 47: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 48: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 49: Latin America mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 50: Latin America mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 51: Latin America mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 52: Latin America mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: Latin America mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 54: Latin America mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 55: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Middle East & Africa mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 59: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 60: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 61: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
目次
Product Code: TMRGL85998

mRNA Vaccine Market - Scope of Report

TMR's report on the global mRNA vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global mRNA vaccine market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mRNA vaccine market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mRNA vaccine market.

Market Snapshot
Market Value in 2023US$ 21.7 Bn
Market Value in 2034US$ 9.6 Bn
CAGR-4.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mRNA vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mRNA vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mRNA vaccine market.

The report delves into the competitive landscape of the global mRNA vaccine market. Key players operating in the global mRNA vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mRNA vaccine market profiled in this report.

Key Questions Answered in Global mRNA vaccine Market Report:

  • What is the sales/revenue generated by mRNA vaccine across all regions during the forecast period?
  • What are the opportunities in the global mRNA vaccine market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

mRNA Vaccine Market - Research Objectives and Research Approach

The comprehensive report on the global mRNA vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global mRNA vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mRNA vaccine market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global mRNA Vaccine Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global mRNA Vaccine Market Analysis and Forecasts, 2020-2034
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. mRNA Vaccines Pipeline
  • 5.3. Regulatory Scenario by Region/Globally
  • 5.4. COVID-19 Pandemic Impact Analysis on Industry

6. Global mRNA Vaccine Market Analysis and Forecasts, By Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Application, 2020-2034
    • 6.3.1. COVID-19
    • 6.3.2. Others
  • 6.4. Market Attractiveness By Application

7. Global mRNA Vaccine Market Analysis and Forecasts, By End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By End-user, 2020-2034
    • 7.3.1. Government Entities
    • 7.3.2. Private Hospitals & Clinics
    • 7.3.3. Others
  • 7.4. Market Attractiveness By End-user

8. Global mRNA Vaccine Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness By Country/Region

9. North America mRNA Vaccine Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Application, 2020-2034
    • 9.2.1. COVID-19
    • 9.2.2. Others
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Government Entities
    • 9.3.2. Private Hospitals & Clinics
    • 9.3.3. Others
  • 9.4. Market Value Forecast By Country, 2020-2034
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Application
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe mRNA Vaccine Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Application, 2020-2034
    • 10.2.1. COVID-19
    • 10.2.2. Others
  • 10.3. Market Value Forecast By End-user, 2020-2034
    • 10.3.1. Government Entities
    • 10.3.2. Private Hospitals & Clinics
    • 10.3.3. Others
  • 10.4. Market Value Forecast By Country, 2020-2034
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Application
    • 10.5.2. By End-user
    • 10.5.3. By Country

11. Asia Pacific mRNA Vaccine Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Application, 2020-2034
    • 11.2.1. COVID-19
    • 11.2.2. Others
  • 11.3. Market Value Forecast By End-user, 2020-2034
    • 11.3.1. Government Entities
    • 11.3.2. Private Hospitals & Clinics
    • 11.3.3. Others
  • 11.4. Market Value Forecast By Country, 2020-2034
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Application
    • 11.5.2. By End-user
    • 11.5.3. By Country

12. Latin America mRNA Vaccine Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Application, 2020-2034
    • 12.2.1. COVID-19
    • 12.2.2. Others
  • 12.3. Market Value Forecast By End-user, 2020-2034
    • 12.3.1. Government Entities
    • 12.3.2. Private Hospitals & Clinics
    • 12.3.3. Others
  • 12.4. Market Value Forecast By Country, 2020-2034
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Application
    • 12.5.2. By End-user
    • 12.5.3. By Country

13. Middle East & Africa mRNA Vaccine Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Application, 2020-2034
    • 13.2.1. COVID-19
    • 13.2.2. Others
  • 13.3. Market Value Forecast By End-user, 2020-2034
    • 13.3.1. Government Entities
    • 13.3.2. Private Hospitals & Clinics
    • 13.3.3. Others
  • 13.4. Market Value Forecast By Country, 2020-2034
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Application
    • 13.5.2. By End-user
    • 13.5.3. By Country

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Pfizer, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Moderna Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Novartis AG
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Sanofi
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Arcturus Therapeutics
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Gennova Biopharmaceuticals Ltd
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Aimei Vaccine Co., Ltd
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview